착상 전 유전자 진단에 관한 연구

No doubt, assisted reproductive technologies may contribute substantially to human well-being. However the reproductive revolution raises a wave of moral questions concerning the responsibilities of prospective parents, the scientists involved, and society as a whole. This holds true particularly for preimplantation genetic diagnosis(PGD), which aims at a selective transfer. PGD was primarily developed in response to requests for help from people at high risk of passing on a serious genetic disorder to their children. This research considers ethical and legal aspects of preimplantation genetic testing. Possible categorical moral objections to PGD concern the biopsy, the selection of embryos, the burdens and risks of the preceding in vitro fertilization procedure, the slippery slope, and the link with embryo research. This study will differentiate human embryonic stem cells from other types of stem cells and frames the ethical and legal controversy surrounding human embryonic stem cell research, including patentability, too. The Genetic Information Nondiscrimination Act of 2008 (GINA) prohibits discrimination based on genetic information by health insurers and employers. This research is forcused on analysising the legal, ethical standards in Bioethical and Legal Issues on PGD method of Embryos, and comparing the foreign laws with the Law on Bioethics and Biosafety(the Bioethics Law) for the desirable amendsment of the existing Bioethics Law in the viewpoint of public policy. After the Law on Bioethics and Biosafety has been enacted since 2005, Preimplantation genetic diagnosis(PGD) for embryo and Prenatal diagnosis(PD) for fetus are regulated by this law. The Purpose of this study is to examine the problems of the Use and Protection of Preimplantation genetic Diagnosis in Korea and to suggest thereby the way that can improve the law-related perspective.